[Structured reporting in oncologic hybrid imaging: a consensus recommendation].
暂无分享,去创建一个
T. Derlin | H. Schlemmer | B. Krause | F. Giesel | M. Weber | G. Antoch | L. Umutlu | K. Herrmann | J. Kotzerke | T. Persigehl | M. Eiber | D. Pinto dos Santos | S. Gatidis | C. Pfannenberg
[1] T. Beyer,et al. PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[2] T. Beyer,et al. State of affairs of hybrid imaging in Europe: two multi-national surveys from 2017 , 2019, Insights into Imaging.
[3] Konstantin Nikolaou,et al. Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation , 2019, Nuklearmedizin.
[4] T. Beyer,et al. An International Survey on Clinical Reporting of PET/CT Examinations: A Starting Point for Cross-Specialty Engagement , 2018, The Journal of Nuclear Medicine.
[5] W. Vach,et al. Practice-based evidence for the clinical benefit of PET/CT—results of the first oncologic PET/CT registry in Germany , 2018, European Journal of Nuclear Medicine and Molecular Imaging.
[6] T. Beyer,et al. An international survey on hybrid imaging: do technology advances preempt our training and education efforts? , 2018, Cancer Imaging.
[7] T. Derlin,et al. Molecular Imaging in Oncology Using Positron Emission Tomography. , 2018, Deutsches Arzteblatt international.
[8] T. Beyer,et al. Life is not black and white, nor just Shades of Gray , 2018, European Journal of Nuclear Medicine and Molecular Imaging.
[9] Frederik L. Giesel,et al. Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT , 2017, The Journal of Nuclear Medicine.
[10] Eric J. W. Visser,et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Bruce D Cheson,et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] John O. Prior,et al. Reporting Guidance for Oncologic 18F-FDG PET/CT Imaging , 2013, The Journal of Nuclear Medicine.
[13] R. Boellaard,et al. Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis , 2012, The Journal of Nuclear Medicine.
[14] T. Beyer,et al. Variations in Clinical PET/CT Operations: Results of an International Survey of Active PET/CT Users , 2011, The Journal of Nuclear Medicine.
[15] J. Radford,et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[16] R. Coleman,et al. PET and PET/CT Reports: Observations from the National Oncologic PET Registry , 2010, Journal of Nuclear Medicine.
[17] R. Wahl,et al. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.
[18] R. Coleman,et al. Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry , 2008, Journal of Nuclear Medicine.
[19] Barry A Siegel,et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] I. Carrió. EANM-ESR white paper on multimodality imaging , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[21] M. Reiser,et al. White paper of the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM) on multimodality imaging , 2007, European Radiology.
[22] M. Reiser,et al. White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[23] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.